Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC29H28FN7O4S2 |
InChIKeyJRPONRKZBDUIEH-UHFFFAOYSA-N |
CAS Registry1023310-86-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | - | - |